Please login to the form below

Not currently logged in
Email:
Password:

BMS’ Brian Daniels to retire

He will step down from role as senior VP, global development and medical affairs
BMS Brian Daniels

Dr Brian Daniels is to retire from his role as senior VP, global development and medical affairs at Bristol-Myers Squibb (BMS) on July 1, 2014.

Dr Daniels has been with BMS since 2000 as VP of the immunology, pulmonary, and dermatology therapeutic area where he worked on such compounds as rheumatoid arthritis drug Orencia (abatacept). He took on his current role in 2008.

Francis Cuss, executive vice president and chief scientific officer, BMS said: "He has been a champion of the patients we serve, and I want to sincerely thank him for his loyalty and dedication to Bristol-Myers Squibb."

Prior to joining BMS, Dr Daniels spent four years at Merck Research Laboratories in clinical research where he ultimately assumed the role of senior director, pulmonary and immunology. He has also worked in clinical research at Genentech.

7th May 2014

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics